Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Katharina L. Wiest"'
Publikováno v:
Harm Reduction Journal, Vol 20, Iss 1, Pp 1-13 (2023)
Abstract Background BUP-XR (SUBLOCADE®) is the first buprenorphine extended-release subcutaneous injection approved in the USA for monthly treatment of moderate-to-severe opioid use disorder (OUD). Among patients with OUD, those who inject or use hi
Externí odkaz:
https://doaj.org/article/c923bb74f49c412ea6b467cd77d997da